SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-24-060159
Filing Date
2024-07-09
Accepted
2024-07-09 17:04:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209134-8k425_arcabio.htm 425 29606
2 FORM OF AMENDMENT ea020913401ex10-1_arcabio.htm EX-10.1 11118
3 FORM OF A&R SUBSCRIPTION AGREEMENT ea020913401ex10-2_arcabio.htm EX-10.2 148948
  Complete submission text file 0001213900-24-060159.txt   191733
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filed by) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-22873 | Film No.: 241108025
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)